Vandetanib angiogenesis inhibitors

Zactima - vandetanib - ZD-6474 - ZD6474 - ZD 6474 - caprelsa



Trial Studied treatment Control Patients Size Study type Results NCT

Lung cancer (metastatic) - chemotherapy in all type of patients - angiogenesis inhibitors in all type of patients

Heymach, 2007 vandetanib plus docetaxel placebo plus docetaxelNA
Aisner, 2013vandetanib NA
Natale, 2011Vandetanib gefitinib 168 (83/85)
Lee ZEPHYR, 2012Vandetanib placebo 924 (617/307)
Ahn, 2013vandetanib maintenance NA
de Boer, 2011Vandetanib plus pemetrexed 534 (256/278)
De Boer, 2011vandetanib plus pemetrexedpemetrexedNA
Natale, 2009Vandetanib versus gefitinib NA